 | • レポートコード：QYR2104Z5866 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、血管炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（大血管炎治療、中血管炎治療、小血管炎治療）、用途別市場規模（病院・診療所、診断センター、研究所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・血管炎治療の市場動向 ・企業の競争状況、市場シェア ・血管炎治療の種類別市場規模（大血管炎治療、中血管炎治療、小血管炎治療） ・血管炎治療の用途別市場規模（病院・診療所、診断センター、研究所、その他） ・血管炎治療の北米市場規模2016-2027（アメリカ、カナダ） ・血管炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・血管炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・血管炎治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・血管炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbvie、Ablynx、Amgen、Anthera Pharmaceuticals、Aspen Pharmacare Holdings、Astrazeneca、Baxter、Biogen、Bristol-Myers Squibb、Celgene、Celltrion、Chemocentryx、Chugai Pharma Usa、Eisai、Eli Lilly、F. Hoffmann-La Roche、Genentech、Gilead、Glaxosmithkline、Human Genome Sciences） ・結論 |
Vasculitis is a general term that refers to inflammation of blood vessels. When blood vessels become inflamed, they may become weakened, stretch, and either increase in size or become narrow — even to the point of closing entirely. Vasculitis can affect people of all ages, but there are types of vasculitis that occur in certain age groups more often than others.
The market for vasculitis across the globe is expected to propel significantly during the forecast period. The factors driving the vasculitis market are rising incidences of metabolic disorders and circulatory diseases such as peripheral arterial disease (PAD) and high demand for minimally invasive procedures. In addition, the rising healthcare expenditure and R&D vasculitis treatment and supportive reimbursement policies are estimated to impact the market positively during the forecast period.
Market Analysis and Insights: Global Vasculitis Treatment Market
The global Vasculitis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Vasculitis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Vasculitis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Vasculitis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Vasculitis Treatment market.
Global Vasculitis Treatment Scope and Market Size
Vasculitis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Vasculitis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Large Vasculitis Treatment
Medium Vasculitis Treatment
Small Vasculitis Treatment
Segment by Application
Hospitals And Clinics
Diagnosis Center
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbvie
Ablynx
Amgen
Anthera Pharmaceuticals
Aspen Pharmacare Holdings
Astrazeneca
Baxter
Biogen
Bristol-Myers Squibb
Anthera Pharmaceuticals
Aspen Pharmacare Holdings
Chemocentryx
Chugai Pharma Usa
Eisai
Eli Lilly
F. Hoffmann-La Roche
Genentech
Gilead
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Vasculitis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Large Vasculitis Treatment
1.2.3 Medium Vasculitis Treatment
1.2.4 Small Vasculitis Treatment
1.3 Market by Application
1.3.1 Global Vasculitis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals And Clinics
1.3.3 Diagnosis Center
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Vasculitis Treatment Market Perspective (2016-2027)
2.2 Vasculitis Treatment Growth Trends by Regions
2.2.1 Vasculitis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Vasculitis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Vasculitis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Vasculitis Treatment Industry Dynamic
2.3.1 Vasculitis Treatment Market Trends
2.3.2 Vasculitis Treatment Market Drivers
2.3.3 Vasculitis Treatment Market Challenges
2.3.4 Vasculitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Vasculitis Treatment Players by Revenue
3.1.1 Global Top Vasculitis Treatment Players by Revenue (2016-2021)
3.1.2 Global Vasculitis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Vasculitis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Vasculitis Treatment Revenue
3.4 Global Vasculitis Treatment Market Concentration Ratio
3.4.1 Global Vasculitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Vasculitis Treatment Revenue in 2020
3.5 Vasculitis Treatment Key Players Head office and Area Served
3.6 Key Players Vasculitis Treatment Product Solution and Service
3.7 Date of Enter into Vasculitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Vasculitis Treatment Breakdown Data by Type
4.1 Global Vasculitis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Vasculitis Treatment Forecasted Market Size by Type (2022-2027)
5 Vasculitis Treatment Breakdown Data by Application
5.1 Global Vasculitis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Vasculitis Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Vasculitis Treatment Market Size (2016-2027)
6.2 North America Vasculitis Treatment Market Size by Type
6.2.1 North America Vasculitis Treatment Market Size by Type (2016-2021)
6.2.2 North America Vasculitis Treatment Market Size by Type (2022-2027)
6.2.3 North America Vasculitis Treatment Market Size by Type (2016-2027)
6.3 North America Vasculitis Treatment Market Size by Application
6.3.1 North America Vasculitis Treatment Market Size by Application (2016-2021)
6.3.2 North America Vasculitis Treatment Market Size by Application (2022-2027)
6.3.3 North America Vasculitis Treatment Market Size by Application (2016-2027)
6.4 North America Vasculitis Treatment Market Size by Country
6.4.1 North America Vasculitis Treatment Market Size by Country (2016-2021)
6.4.2 North America Vasculitis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Vasculitis Treatment Market Size (2016-2027)
7.2 Europe Vasculitis Treatment Market Size by Type
7.2.1 Europe Vasculitis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Vasculitis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Vasculitis Treatment Market Size by Type (2016-2027)
7.3 Europe Vasculitis Treatment Market Size by Application
7.3.1 Europe Vasculitis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Vasculitis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Vasculitis Treatment Market Size by Application (2016-2027)
7.4 Europe Vasculitis Treatment Market Size by Country
7.4.1 Europe Vasculitis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Vasculitis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Vasculitis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Vasculitis Treatment Market Size by Type
8.2.1 Asia-Pacific Vasculitis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Vasculitis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Vasculitis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Vasculitis Treatment Market Size by Application
8.3.1 Asia-Pacific Vasculitis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Vasculitis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Vasculitis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Vasculitis Treatment Market Size by Region
8.4.1 Asia-Pacific Vasculitis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Vasculitis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Vasculitis Treatment Market Size (2016-2027)
9.2 Latin America Vasculitis Treatment Market Size by Type
9.2.1 Latin America Vasculitis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Vasculitis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Vasculitis Treatment Market Size by Type (2016-2027)
9.3 Latin America Vasculitis Treatment Market Size by Application
9.3.1 Latin America Vasculitis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Vasculitis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Vasculitis Treatment Market Size by Application (2016-2027)
9.4 Latin America Vasculitis Treatment Market Size by Country
9.4.1 Latin America Vasculitis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Vasculitis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Vasculitis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Vasculitis Treatment Market Size by Type
10.2.1 Middle East & Africa Vasculitis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Vasculitis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Vasculitis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Vasculitis Treatment Market Size by Application
10.3.1 Middle East & Africa Vasculitis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Vasculitis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Vasculitis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Vasculitis Treatment Market Size by Country
10.4.1 Middle East & Africa Vasculitis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Vasculitis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbvie
11.1.1 Abbvie Company Details
11.1.2 Abbvie Business Overview
11.1.3 Abbvie Vasculitis Treatment Introduction
11.1.4 Abbvie Revenue in Vasculitis Treatment Business (2016-2021)
11.1.5 Abbvie Recent Development
11.2 Ablynx
11.2.1 Ablynx Company Details
11.2.2 Ablynx Business Overview
11.2.3 Ablynx Vasculitis Treatment Introduction
11.2.4 Ablynx Revenue in Vasculitis Treatment Business (2016-2021)
11.2.5 Ablynx Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Vasculitis Treatment Introduction
11.3.4 Amgen Revenue in Vasculitis Treatment Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Anthera Pharmaceuticals
11.4.1 Anthera Pharmaceuticals Company Details
11.4.2 Anthera Pharmaceuticals Business Overview
11.4.3 Anthera Pharmaceuticals Vasculitis Treatment Introduction
11.4.4 Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2016-2021)
11.4.5 Anthera Pharmaceuticals Recent Development
11.5 Aspen Pharmacare Holdings
11.5.1 Aspen Pharmacare Holdings Company Details
11.5.2 Aspen Pharmacare Holdings Business Overview
11.5.3 Aspen Pharmacare Holdings Vasculitis Treatment Introduction
11.5.4 Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2016-2021)
11.5.5 Aspen Pharmacare Holdings Recent Development
11.6 Astrazeneca
11.6.1 Astrazeneca Company Details
11.6.2 Astrazeneca Business Overview
11.6.3 Astrazeneca Vasculitis Treatment Introduction
11.6.4 Astrazeneca Revenue in Vasculitis Treatment Business (2016-2021)
11.6.5 Astrazeneca Recent Development
11.7 Baxter
11.7.1 Baxter Company Details
11.7.2 Baxter Business Overview
11.7.3 Baxter Vasculitis Treatment Introduction
11.7.4 Baxter Revenue in Vasculitis Treatment Business (2016-2021)
11.7.5 Baxter Recent Development
11.8 Biogen
11.8.1 Biogen Company Details
11.8.2 Biogen Business Overview
11.8.3 Biogen Vasculitis Treatment Introduction
11.8.4 Biogen Revenue in Vasculitis Treatment Business (2016-2021)
11.8.5 Biogen Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Vasculitis Treatment Introduction
11.9.4 Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2016-2021)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Celgene
11.10.1 Celgene Company Details
11.10.2 Celgene Business Overview
11.10.3 Celgene Vasculitis Treatment Introduction
11.10.4 Celgene Revenue in Vasculitis Treatment Business (2016-2021)
11.10.5 Celgene Recent Development
11.11 Celltrion
11.11.1 Celltrion Company Details
11.11.2 Celltrion Business Overview
11.11.3 Celltrion Vasculitis Treatment Introduction
11.11.4 Celltrion Revenue in Vasculitis Treatment Business (2016-2021)
11.11.5 Celltrion Recent Development
11.12 Chemocentryx
11.12.1 Chemocentryx Company Details
11.12.2 Chemocentryx Business Overview
11.12.3 Chemocentryx Vasculitis Treatment Introduction
11.12.4 Chemocentryx Revenue in Vasculitis Treatment Business (2016-2021)
11.12.5 Chemocentryx Recent Development
11.13 Chugai Pharma Usa
11.13.1 Chugai Pharma Usa Company Details
11.13.2 Chugai Pharma Usa Business Overview
11.13.3 Chugai Pharma Usa Vasculitis Treatment Introduction
11.13.4 Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2016-2021)
11.13.5 Chugai Pharma Usa Recent Development
11.14 Eisai
11.14.1 Eisai Company Details
11.14.2 Eisai Business Overview
11.14.3 Eisai Vasculitis Treatment Introduction
11.14.4 Eisai Revenue in Vasculitis Treatment Business (2016-2021)
11.14.5 Eisai Recent Development
11.15 Eli Lilly
11.15.1 Eli Lilly Company Details
11.15.2 Eli Lilly Business Overview
11.15.3 Eli Lilly Vasculitis Treatment Introduction
11.15.4 Eli Lilly Revenue in Vasculitis Treatment Business (2016-2021)
11.15.5 Eli Lilly Recent Development
11.16 F. Hoffmann-La Roche
11.16.1 F. Hoffmann-La Roche Company Details
11.16.2 F. Hoffmann-La Roche Business Overview
11.16.3 F. Hoffmann-La Roche Vasculitis Treatment Introduction
11.16.4 F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2016-2021)
11.16.5 F. Hoffmann-La Roche Recent Development
11.17 Genentech
11.17.1 Genentech Company Details
11.17.2 Genentech Business Overview
11.17.3 Genentech Vasculitis Treatment Introduction
11.17.4 Genentech Revenue in Vasculitis Treatment Business (2016-2021)
11.17.5 Genentech Recent Development
11.18 Gilead
11.18.1 Gilead Company Details
11.18.2 Gilead Business Overview
11.18.3 Gilead Vasculitis Treatment Introduction
11.18.4 Gilead Revenue in Vasculitis Treatment Business (2016-2021)
11.18.5 Gilead Recent Development
11.18 Glaxosmithkline
.1 Glaxosmithkline Company Details
.2 Glaxosmithkline Business Overview
.3 Glaxosmithkline Vasculitis Treatment Introduction
.4 Glaxosmithkline Revenue in Vasculitis Treatment Business (2016-2021)
.5 Glaxosmithkline Recent Development
11.20 Human Genome Sciences
11.20.1 Human Genome Sciences Company Details
11.20.2 Human Genome Sciences Business Overview
11.20.3 Human Genome Sciences Vasculitis Treatment Introduction
11.20.4 Human Genome Sciences Revenue in Vasculitis Treatment Business (2016-2021)
11.20.5 Human Genome Sciences Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Vasculitis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Large Vasculitis Treatment
Table 3. Key Players of Medium Vasculitis Treatment
Table 4. Key Players of Small Vasculitis Treatment
Table 5. Global Vasculitis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Vasculitis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Vasculitis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Vasculitis Treatment Market Share by Regions (2016-2021)
Table 9. Global Vasculitis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Vasculitis Treatment Market Share by Regions (2022-2027)
Table 11. Vasculitis Treatment Market Trends
Table 12. Vasculitis Treatment Market Drivers
Table 13. Vasculitis Treatment Market Challenges
Table 14. Vasculitis Treatment Market Restraints
Table 15. Global Vasculitis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Vasculitis Treatment Market Share by Players (2016-2021)
Table 17. Global Top Vasculitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Treatment as of 2020)
Table 18. Ranking of Global Top Vasculitis Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Vasculitis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Vasculitis Treatment Product Solution and Service
Table 22. Date of Enter into Vasculitis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Vasculitis Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Vasculitis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Vasculitis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Vasculitis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Vasculitis Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Vasculitis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Vasculitis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Vasculitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Vasculitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Vasculitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Vasculitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Vasculitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Vasculitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Vasculitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Vasculitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Vasculitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Vasculitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Vasculitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Vasculitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Vasculitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Vasculitis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Vasculitis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Vasculitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Vasculitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Vasculitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Vasculitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Vasculitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Vasculitis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Vasculitis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Vasculitis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Vasculitis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Vasculitis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Vasculitis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbvie Company Details
Table 63. Abbvie Business Overview
Table 64. Abbvie Vasculitis Treatment Product
Table 65. Abbvie Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 66. Abbvie Recent Development
Table 67. Ablynx Company Details
Table 68. Ablynx Business Overview
Table 69. Ablynx Vasculitis Treatment Product
Table 70. Ablynx Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 71. Ablynx Recent Development
Table 72. Amgen Company Details
Table 73. Amgen Business Overview
Table 74. Amgen Vasculitis Treatment Product
Table 75. Amgen Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 76. Amgen Recent Development
Table 77. Anthera Pharmaceuticals Company Details
Table 78. Anthera Pharmaceuticals Business Overview
Table 79. Anthera Pharmaceuticals Vasculitis Treatment Product
Table 80. Anthera Pharmaceuticals Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 81. Anthera Pharmaceuticals Recent Development
Table 82. Aspen Pharmacare Holdings Company Details
Table 83. Aspen Pharmacare Holdings Business Overview
Table 84. Aspen Pharmacare Holdings Vasculitis Treatment Product
Table 85. Aspen Pharmacare Holdings Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 86. Aspen Pharmacare Holdings Recent Development
Table 87. Astrazeneca Company Details
Table 88. Astrazeneca Business Overview
Table 89. Astrazeneca Vasculitis Treatment Product
Table 90. Astrazeneca Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 91. Astrazeneca Recent Development
Table 92. Baxter Company Details
Table 93. Baxter Business Overview
Table 94. Baxter Vasculitis Treatment Product
Table 95. Baxter Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 96. Baxter Recent Development
Table 97. Biogen Company Details
Table 98. Biogen Business Overview
Table 99. Biogen Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 100. Biogen Recent Development
Table 101. Bristol-Myers Squibb Company Details
Table 102. Bristol-Myers Squibb Business Overview
Table 103. Bristol-Myers Squibb Vasculitis Treatment Product
Table 104. Bristol-Myers Squibb Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 105. Bristol-Myers Squibb Recent Development
Table 106. Celgene Company Details
Table 107. Celgene Business Overview
Table 108. Celgene Vasculitis Treatment Product
Table 109. Celgene Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 110. Celgene Recent Development
Table 111. Celltrion Company Details
Table 112. Celltrion Business Overview
Table 113. Celltrion Vasculitis Treatment Product
Table 114. Celltrion Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 115. Celltrion Recent Development
Table 116. Chemocentryx Company Details
Table 117. Chemocentryx Business Overview
Table 118. Chemocentryx Vasculitis Treatment Product
Table 119. Chemocentryx Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 120. Chemocentryx Recent Development
Table 121. Chugai Pharma Usa Company Details
Table 122. Chugai Pharma Usa Business Overview
Table 123. Chugai Pharma Usa Vasculitis Treatment Product
Table 124. Chugai Pharma Usa Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 125. Chugai Pharma Usa Recent Development
Table 126. Eisai Company Details
Table 127. Eisai Business Overview
Table 128. Eisai Vasculitis Treatment Product
Table 129. Eisai Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 130. Eisai Recent Development
Table 131. Eli Lilly Company Details
Table 132. Eli Lilly Business Overview
Table 133. Eli Lilly Vasculitis Treatment Product
Table 134. Eli Lilly Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 135. Eli Lilly Recent Development
Table 136. F. Hoffmann-La Roche Company Details
Table 137. F. Hoffmann-La Roche Business Overview
Table 138. F. Hoffmann-La Roche Vasculitis Treatment Product
Table 139. F. Hoffmann-La Roche Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 140. F. Hoffmann-La Roche Recent Development
Table 141. Genentech Company Details
Table 142. Genentech Business Overview
Table 143. Genentech Vasculitis Treatment Product
Table 144. Genentech Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 145. Genentech Recent Development
Table 146. Gilead Company Details
Table 147. Gilead Business Overview
Table 148. Gilead Vasculitis Treatment Product
Table 149. Gilead Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 150. Gilead Recent Development
Table 151. Glaxosmithkline Company Details
Table 152. Glaxosmithkline Business Overview
Table 153. Glaxosmithkline Vasculitis Treatment Product
Table 154. Glaxosmithkline Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 155. Glaxosmithkline Recent Development
Table 156. Human Genome Sciences Company Details
Table 157. Human Genome Sciences Business Overview
Table 158. Human Genome Sciences Vasculitis Treatment Product
Table 159. Human Genome Sciences Revenue in Vasculitis Treatment Business (2016-2021) & (US$ Million)
Table 160. Human Genome Sciences Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Vasculitis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Large Vasculitis Treatment Features
Figure 3. Medium Vasculitis Treatment Features
Figure 4. Small Vasculitis Treatment Features
Figure 5. Global Vasculitis Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals And Clinics Case Studies
Figure 7. Diagnosis Center Case Studies
Figure 8. Research Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. Vasculitis Treatment Report Years Considered
Figure 11. Global Vasculitis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Vasculitis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Vasculitis Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Vasculitis Treatment Market Share by Regions (2022-2027)
Figure 15. Global Vasculitis Treatment Market Share by Players in 2020
Figure 16. Global Top Vasculitis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Vasculitis Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Vasculitis Treatment Revenue in 2020
Figure 18. Global Vasculitis Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Vasculitis Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Vasculitis Treatment Market Share by Type (2016-2027)
Figure 22. North America Vasculitis Treatment Market Share by Application (2016-2027)
Figure 23. North America Vasculitis Treatment Market Share by Country (2016-2027)
Figure 24. United States Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Vasculitis Treatment Market Share by Type (2016-2027)
Figure 28. Europe Vasculitis Treatment Market Share by Application (2016-2027)
Figure 29. Europe Vasculitis Treatment Market Share by Country (2016-2027)
Figure 30. Germany Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Vasculitis Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Vasculitis Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Vasculitis Treatment Market Share by Region (2016-2027)
Figure 40. China Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Vasculitis Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Vasculitis Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Vasculitis Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Vasculitis Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Vasculitis Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Vasculitis Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Vasculitis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbvie Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 60. Ablynx Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 62. Anthera Pharmaceuticals Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 63. Aspen Pharmacare Holdings Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 64. Astrazeneca Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 65. Baxter Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 66. Biogen Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 68. Celgene Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 69. Celltrion Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 70. Chemocentryx Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 71. Chugai Pharma Usa Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 72. Eisai Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 73. Eli Lilly Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 74. F. Hoffmann-La Roche Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 75. Genentech Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 76. Gilead Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 77. Glaxosmithkline Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 78. Human Genome Sciences Revenue Growth Rate in Vasculitis Treatment Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年） Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The most common symptoms are fever, headache, and neck stiffness. Other symptoms include confusion or altered consciousness, vomiting, and an inability to tolerate …- 世界のミトコンドリアミオパチー診断・治療市場規模・現状・予測（2021年-2027年） Mitochondrial myopathies are types of myopathies associated with mitochondrial disease. On biopsy, the muscle tissue of patients with these diseases usually demonstrate "ragged red" muscle fibers. These ragged-red fibers contain mild accumulations of glycogen and neutral lipids, and may show an incr…
- 世界のHIV診断＆治療市場規模・現状・予測（2021年-2027年） HIV prevalence in Africa, specifically in Southern region is very high as compared to North African region. Approximately 1 out of 4 is suffering from HIV. Southern and Eastern region of Africa has one of the highest prevalence rate of HIV, about 19 million people have HIV. While HIV prevalence is l…
- 世界のHIV診断・治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global HIV Diagnosis and Treatment Market The global HIV Diagnosis and Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
- 世界のてんかん診断・治療市場規模・現状・予測（2021年-2027年） Epilepsy is a neurological disorder affecting the central nervous system. In this medical condition, the brain exhibits abnormal activity, which results in periods of unusual behavior or seizures and sometimes, loss of awareness. Temporary confusion, anxiety, uncontrollable jerking movements of the …